2 December 2015 - The new drug, Keytruda, hailed as a historic step forward in the treatment of advanced melanoma, has been given only a low priority for taxpayer funding.

For more details, go to: http://www.nzherald.co.nz/health/news/article.cfm?c_id=204&objectid=11554719&ref=rss